CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,903 | +32.0% | 13,350 | -34.4% | 0.00% | 0.0% |
| Q4 2022 | $4,471 | -36.1% | 20,350 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $7,000 | -46.2% | 20,350 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $13,000 | -23.5% | 20,350 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $17,000 | -57.5% | 20,350 | -42.0% | 0.01% | -57.9% |
| Q4 2021 | $40,000 | -74.0% | 35,075 | -43.1% | 0.02% | -80.2% |
| Q3 2021 | $154,000 | -30.3% | 61,675 | -17.2% | 0.10% | -28.9% |
| Q2 2021 | $221,000 | -27.8% | 74,500 | -14.5% | 0.14% | -40.0% |
| Q1 2021 | $306,000 | -12.3% | 87,185 | +18.6% | 0.22% | -21.6% |
| Q4 2020 | $349,000 | – | 73,500 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |